回顾声明:HMGB1在NSCLC转移过程中通过转录激活直接调控SNAI1，也通过RSF1‐IT2依赖性间接调控SNAI1

IF 5 2区医学 Q1 ONCOLOGY

Molecular Oncology Pub Date : 2022-12-01 DOI:10.1002/1878-0261.13334

K. Ryan

{"title":"回顾声明:HMGB1在NSCLC转移过程中通过转录激活直接调控SNAI1，也通过RSF1‐IT2依赖性间接调控SNAI1","authors":"K. Ryan","doi":"10.1002/1878-0261.13334","DOIUrl":null,"url":null,"abstract":"The above article, published online on 2 June 2020 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the authors, the journal Editor in Chief, Kevin Ryan, FEBS Press and John Wiley and Sons Ltd. The retraction has been agreed due to the identification of duplications in Figures 2A and 3J and the lack of compelling raw data underlying these figure panels. As a result, the key conclusions of the paper are considered unreliable. The results of an institutional investigation support this decision.","PeriodicalId":51134,"journal":{"name":"Molecular Oncology","volume":null,"pages":null},"PeriodicalIF":5.0000,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Retraction statement: HMGB1 regulates SNAI1 during NSCLC metastasis, both directly, through transcriptional activation, and indirectly, in a RSF1‐IT2‐dependent manner\",\"authors\":\"K. Ryan\",\"doi\":\"10.1002/1878-0261.13334\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The above article, published online on 2 June 2020 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the authors, the journal Editor in Chief, Kevin Ryan, FEBS Press and John Wiley and Sons Ltd. The retraction has been agreed due to the identification of duplications in Figures 2A and 3J and the lack of compelling raw data underlying these figure panels. As a result, the key conclusions of the paper are considered unreliable. The results of an institutional investigation support this decision.\",\"PeriodicalId\":51134,\"journal\":{\"name\":\"Molecular Oncology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":5.0000,\"publicationDate\":\"2022-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Molecular Oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1002/1878-0261.13334\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/1878-0261.13334","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

上述文章于2020年6月2日在线发表在威利在线图书馆（wileyonlinelibrary.com），经作者、期刊主编凯文·瑞安、FEBS出版社和约翰·威利父子有限公司同意撤回。由于图2A和图3J中存在重复，且这些图面板缺乏令人信服的原始数据，因此同意撤回。因此，论文的关键结论被认为是不可靠的。机构调查的结果支持这一决定。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Retraction statement: HMGB1 regulates SNAI1 during NSCLC metastasis, both directly, through transcriptional activation, and indirectly, in a RSF1‐IT2‐dependent manner

The above article, published online on 2 June 2020 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the authors, the journal Editor in Chief, Kevin Ryan, FEBS Press and John Wiley and Sons Ltd. The retraction has been agreed due to the identification of duplications in Figures 2A and 3J and the lack of compelling raw data underlying these figure panels. As a result, the key conclusions of the paper are considered unreliable. The results of an institutional investigation support this decision.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Molecular Oncology 医学-肿瘤学

CiteScore

12.60

自引率

1.50%

发文量

203

审稿时长

6-12 weeks

期刊介绍： Molecular Oncology highlights new discoveries, approaches, and technical developments, in basic, clinical and discovery-driven translational cancer research. It publishes research articles, reviews (by invitation only), and timely science policy articles. The journal is now fully Open Access with all articles published over the past 10 years freely available.